SCHEMBL4970873

SCHEMBL4970873

Cc1nc(Cl)cc([AsH2])n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL113085 0.81 — —
SCHEMBL786227 0.74 — —
SCHEMBL13485361 0.70 — —
SCHEMBL1671480 0.70 — —
SCHEMBL115697 0.70 — —
SCHEMBL13501656 0.70 — —
SCHEMBL28417512 0.68 KMT2A (0.38) —
SCHEMBL20840575 0.68 ALDH1A1 (0.50) —
Hydrochloric Acid SCHEMBL11187707 0.68 NPC1 (0.37) —
SCHEMBL3711167 0.67 MEN1 (0.47) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2951170-B1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2018-10-24 — — EP disclosed
EP-1968956-A2 CALCIUM CHANNEL ANTAGONISTS Icagen, Inc. (US) 2008-09-17 — — EP disclosed
WO-2007073497-A2 CALCIUM CHANNEL ANTAGONISTS ICAGEN, INC. (US) 2007-06-28 — — WO disclosed
Send feedback